Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • New and emerging therapies in cutaneous T-cell lymphoma

    Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino
    02-10-2024
    https://doi.org/10.4081/dr.2024.10002
    1047
    PDF: 562
    HTML: 92
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2355
    PDF: 1389
    HTML: 98
  • Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp

    Uwe Wollina, Andreas Schreiber, Knut Merla, Gunter Haroske
    e57
    13-12-2011
    https://doi.org/10.4081/dr.2011.e57
    1860
    PDF: 709
    HTML: 1021
  • Case of generalized morphea complicated with systemic sclerosis

    Soichiro Sawamura, Katsunari Makino, Hitomi Nakashima, Takamitsu Makino, Satoshi Fukushima
    06-10-2021
    https://doi.org/10.4081/dr.2021.9382
    1531
    PDF: 682
    HTML: 10
  • Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

    Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone
    28-02-2025
    https://doi.org/10.4081/dr.2025.10214
    838
    PDF: 630
    HTML: 8
  • Late reaction to ustekinumab infusion

    Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho
    e2
    09-09-2013
    https://doi.org/10.4081/dr.2013.e2
    3949
    PDF: 653
    HTML: 260
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1041
    PDF: 548
    HTML: 69
  • A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

    Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen
    e14
    14-10-2010
    https://doi.org/10.4081/dr.2010.e14
    4085
    PDF: 820
    HTML: 321
  • Linear immunoglobulin A bullous dermatosis induced by atezolizumab

    Seba Almutairi, Dana Alessa
    08-02-2024
    https://doi.org/10.4081/dr.2024.9923
    565
    PDF: 543
    HTML: 34
  • Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

    Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani
    14-06-2023
    https://doi.org/10.4081/dr.2023.9641
    976
    PDF: 472
    HTML: 19
  • Tight junctions in Hailey-Hailey and Darier’s diseases

    Laura Raiko, Pekka Leinonen, Päivi Hägg, Juha Peltonen, Aarne Oikarinen, Sirkku Peltonen
    e1
    13-11-2009
    https://doi.org/10.4081/dr.2009.e1
    1595
    PDF: 640
    HTML: 1705
  • Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

    Paolo Dapavo, Matteo Megna, Marina Talamonti
    09-08-2024
    https://doi.org/10.4081/dr.2024.9999
    1711
    PDF: 647
    HTML: 93
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1349
    PDF: 647
    HTML: 140
  • Cutaneous papules in a patient with AIDS

    Pascale Quatresooz, Claudine Piérard-Franchimont, Philippe Paquet, Gerald E. Piérard
    e2
    18-01-2010
    https://doi.org/10.4081/dr.2010.e2
    2019
    PDF: 585
    HTML: 127
  • Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

    Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
    01-07-2025
    https://doi.org/10.4081/dr.2025.10315
    487
    PDF: 232
    HTML: 8
  • Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy

    Mafalda Miranda Baleiras, Luís Maduro, Carolina Vasques, Filipa Ferreira, Marta Mesquita Pinto, Ana Martins
    29-07-2021
    https://doi.org/10.4081/dr.2021.9262
    2025
    PDF: 584
    HTML: 20
  • Epidermolysis bullosa acquisita: current diagnosis and therapy

    Christine R. Mehren, Robert Gniadecki
    e38
    28-11-2011
    https://doi.org/10.4081/dr.2011.e38
    1517
    PDF: 821
    HTML: 123
  • Soluble CD27 and MIF as possible serum biomarkers of vitiligo activity in Egyptian patients in Sharkia Governorate

    Mohamed Ibrahim El-Ghareeb, Sahar ElMokadem, Basma Elsayed, Naglaa Khalifa
    20-12-2019
    https://doi.org/10.4081/dr.2019.8265
    1025
    PDF: 662
    HTML: 32
  • Certolizumab to treat hidradenitis suppurativa

    Asem Shadid, Saud Alobaida, Yousef Binamer
    27-10-2022
    https://doi.org/10.4081/dr.2022.9566
    1922
    PDF: 710
    HTML: 27
  • Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review

    Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac
    23-10-2024
    https://doi.org/10.4081/dr.2024.10010
    573
    PDF: 330
    SUPPLEMENTARY MATERIAL: 138
    HTML: 13
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1292
    PDF: 394
    HTML: 44
  • Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

    Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin
    12-09-2023
    https://doi.org/10.4081/dr.2023.9773
    902
    PDF: 451
    HTML: 16
  • Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

    Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong
    17-03-2022
    https://doi.org/10.4081/dr.2022.9444
    1099
    PDF: 583
    HTML: 22
  • Erythrodermic psoriasis improved by tildrakizumab

    Giampaolo Trevisan, Lerica Germi, Luigi Naldi
    23-11-2022
    https://doi.org/10.4081/dr.2022.9448
    1126
    PDF: 603
    HTML: 19
  • A rare case of keloid combined with bullous pemphigoid

    Ying Zhang, Yiyi Gong, Xiangguang Shi, Huyan Chen, Yining Wei, Wenyu Wu, Mengguo Liu
    09-10-2025
    https://doi.org/10.4081/dr.2025.10484
    228
    PDF: 131
1 - 25 of 101 items 1 2 3 4 5 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy